Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Inhalers and Nebulizers Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4528224
    • |
  • 12 April, 2023
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Medical Devices & Consumables

Inhalers and nebulizers are two different devices used to deliver quick-relief medicines (also called rescue or fast-acting medicines) or long-term control medicines (also called controller or maintenance medicines) directly into the lungs
According to our (Global Info Research) latest study, the global Inhalers and Nebulizers market size was valued at USD 14410 million in 2022 and is forecast to a readjusted size of USD 18610 million by 2029 with a CAGR of 3.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva, etc. Global top five manufacturers hold a share about 75%. North America is the largest market of Inhalers and Nebulizers, holds a share over 35%. In terms of product, the Inhalers holds a share of over 90%. And in terms of application, the largest application field is Asthma, with a share of over 45%.
This report is a detailed and comprehensive analysis for global Inhalers and Nebulizers market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Inhalers and Nebulizers market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Inhalers and Nebulizers market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Inhalers and Nebulizers market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Inhalers and Nebulizers market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inhalers and Nebulizers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inhalers and Nebulizers market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Inhalers and Nebulizers market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Inhalers
Nebulizer
Market segment by Application
Asthma
COPD
Others
Major players covered
GSK
AstraZeneca
Chiesi
Boehringer Ingelheim
Novartis
Teva
Organon
PARI GmbH
Omron
Philips
Drive DeVilbiss Healthcare
Yuwell
Leyi
Folee
Beurer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhalers and Nebulizers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inhalers and Nebulizers, with price, sales, revenue and global market share of Inhalers and Nebulizers from 2018 to 2023.
Chapter 3, the Inhalers and Nebulizers competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhalers and Nebulizers breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Inhalers and Nebulizers market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inhalers and Nebulizers.
Chapter 14 and 15, to describe Inhalers and Nebulizers sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Inhalers and Nebulizers
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Inhalers and Nebulizers Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Inhalers
    • 1.3.3 Nebulizer
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Inhalers and Nebulizers Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Asthma
    • 1.4.3 COPD
    • 1.4.4 Others
  • 1.5 Global Inhalers and Nebulizers Market Size & Forecast
    • 1.5.1 Global Inhalers and Nebulizers Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Inhalers and Nebulizers Sales Quantity (2018-2029)
    • 1.5.3 Global Inhalers and Nebulizers Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Inhalers and Nebulizers Product and Services
    • 2.1.4 GSK Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca Inhalers and Nebulizers Product and Services
    • 2.2.4 AstraZeneca Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 AstraZeneca Recent Developments/Updates
  • 2.3 Chiesi
    • 2.3.1 Chiesi Details
    • 2.3.2 Chiesi Major Business
    • 2.3.3 Chiesi Inhalers and Nebulizers Product and Services
    • 2.3.4 Chiesi Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Chiesi Recent Developments/Updates
  • 2.4 Boehringer Ingelheim
    • 2.4.1 Boehringer Ingelheim Details
    • 2.4.2 Boehringer Ingelheim Major Business
    • 2.4.3 Boehringer Ingelheim Inhalers and Nebulizers Product and Services
    • 2.4.4 Boehringer Ingelheim Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Inhalers and Nebulizers Product and Services
    • 2.5.4 Novartis Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Teva
    • 2.6.1 Teva Details
    • 2.6.2 Teva Major Business
    • 2.6.3 Teva Inhalers and Nebulizers Product and Services
    • 2.6.4 Teva Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Teva Recent Developments/Updates
  • 2.7 Organon
    • 2.7.1 Organon Details
    • 2.7.2 Organon Major Business
    • 2.7.3 Organon Inhalers and Nebulizers Product and Services
    • 2.7.4 Organon Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Organon Recent Developments/Updates
  • 2.8 PARI GmbH
    • 2.8.1 PARI GmbH Details
    • 2.8.2 PARI GmbH Major Business
    • 2.8.3 PARI GmbH Inhalers and Nebulizers Product and Services
    • 2.8.4 PARI GmbH Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 PARI GmbH Recent Developments/Updates
  • 2.9 Omron
    • 2.9.1 Omron Details
    • 2.9.2 Omron Major Business
    • 2.9.3 Omron Inhalers and Nebulizers Product and Services
    • 2.9.4 Omron Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Omron Recent Developments/Updates
  • 2.10 Philips
    • 2.10.1 Philips Details
    • 2.10.2 Philips Major Business
    • 2.10.3 Philips Inhalers and Nebulizers Product and Services
    • 2.10.4 Philips Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Philips Recent Developments/Updates
  • 2.11 Drive DeVilbiss Healthcare
    • 2.11.1 Drive DeVilbiss Healthcare Details
    • 2.11.2 Drive DeVilbiss Healthcare Major Business
    • 2.11.3 Drive DeVilbiss Healthcare Inhalers and Nebulizers Product and Services
    • 2.11.4 Drive DeVilbiss Healthcare Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Drive DeVilbiss Healthcare Recent Developments/Updates
  • 2.12 Yuwell
    • 2.12.1 Yuwell Details
    • 2.12.2 Yuwell Major Business
    • 2.12.3 Yuwell Inhalers and Nebulizers Product and Services
    • 2.12.4 Yuwell Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Yuwell Recent Developments/Updates
  • 2.13 Leyi
    • 2.13.1 Leyi Details
    • 2.13.2 Leyi Major Business
    • 2.13.3 Leyi Inhalers and Nebulizers Product and Services
    • 2.13.4 Leyi Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Leyi Recent Developments/Updates
  • 2.14 Folee
    • 2.14.1 Folee Details
    • 2.14.2 Folee Major Business
    • 2.14.3 Folee Inhalers and Nebulizers Product and Services
    • 2.14.4 Folee Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Folee Recent Developments/Updates
  • 2.15 Beurer
    • 2.15.1 Beurer Details
    • 2.15.2 Beurer Major Business
    • 2.15.3 Beurer Inhalers and Nebulizers Product and Services
    • 2.15.4 Beurer Inhalers and Nebulizers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Beurer Recent Developments/Updates

3 Competitive Environment: Inhalers and Nebulizers by Manufacturer

  • 3.1 Global Inhalers and Nebulizers Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Inhalers and Nebulizers Revenue by Manufacturer (2018-2023)
  • 3.3 Global Inhalers and Nebulizers Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Inhalers and Nebulizers by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Inhalers and Nebulizers Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Inhalers and Nebulizers Manufacturer Market Share in 2022
  • 3.5 Inhalers and Nebulizers Market: Overall Company Footprint Analysis
    • 3.5.1 Inhalers and Nebulizers Market: Region Footprint
    • 3.5.2 Inhalers and Nebulizers Market: Company Product Type Footprint
    • 3.5.3 Inhalers and Nebulizers Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Inhalers and Nebulizers Market Size by Region
    • 4.1.1 Global Inhalers and Nebulizers Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Inhalers and Nebulizers Consumption Value by Region (2018-2029)
    • 4.1.3 Global Inhalers and Nebulizers Average Price by Region (2018-2029)
  • 4.2 North America Inhalers and Nebulizers Consumption Value (2018-2029)
  • 4.3 Europe Inhalers and Nebulizers Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Inhalers and Nebulizers Consumption Value (2018-2029)
  • 4.5 South America Inhalers and Nebulizers Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Inhalers and Nebulizers Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Inhalers and Nebulizers Sales Quantity by Type (2018-2029)
  • 5.2 Global Inhalers and Nebulizers Consumption Value by Type (2018-2029)
  • 5.3 Global Inhalers and Nebulizers Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Inhalers and Nebulizers Sales Quantity by Application (2018-2029)
  • 6.2 Global Inhalers and Nebulizers Consumption Value by Application (2018-2029)
  • 6.3 Global Inhalers and Nebulizers Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Inhalers and Nebulizers Sales Quantity by Type (2018-2029)
  • 7.2 North America Inhalers and Nebulizers Sales Quantity by Application (2018-2029)
  • 7.3 North America Inhalers and Nebulizers Market Size by Country
    • 7.3.1 North America Inhalers and Nebulizers Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Inhalers and Nebulizers Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Inhalers and Nebulizers Sales Quantity by Type (2018-2029)
  • 8.2 Europe Inhalers and Nebulizers Sales Quantity by Application (2018-2029)
  • 8.3 Europe Inhalers and Nebulizers Market Size by Country
    • 8.3.1 Europe Inhalers and Nebulizers Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Inhalers and Nebulizers Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Inhalers and Nebulizers Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Inhalers and Nebulizers Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Inhalers and Nebulizers Market Size by Region
    • 9.3.1 Asia-Pacific Inhalers and Nebulizers Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Inhalers and Nebulizers Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Inhalers and Nebulizers Sales Quantity by Type (2018-2029)
  • 10.2 South America Inhalers and Nebulizers Sales Quantity by Application (2018-2029)
  • 10.3 South America Inhalers and Nebulizers Market Size by Country
    • 10.3.1 South America Inhalers and Nebulizers Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Inhalers and Nebulizers Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Inhalers and Nebulizers Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Inhalers and Nebulizers Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Inhalers and Nebulizers Market Size by Country
    • 11.3.1 Middle East & Africa Inhalers and Nebulizers Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Inhalers and Nebulizers Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Inhalers and Nebulizers Market Drivers
  • 12.2 Inhalers and Nebulizers Market Restraints
  • 12.3 Inhalers and Nebulizers Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Inhalers and Nebulizers and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Inhalers and Nebulizers
  • 13.3 Inhalers and Nebulizers Production Process
  • 13.4 Inhalers and Nebulizers Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Inhalers and Nebulizers Typical Distributors
  • 14.3 Inhalers and Nebulizers Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Inhalers and Nebulizers. Industry analysis & Market Report on Inhalers and Nebulizers is a syndicated market report, published as Global Inhalers and Nebulizers Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Inhalers and Nebulizers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,232.92
    		4,849.38
    		6,465.84
    		541,105.20
    		811,657.80
    		1,082,210.40
    		290,510.40
    		435,765.60
    		581,020.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo